Nchi: Australia
Lugha: Kiingereza
Chanzo: Department of Health (Therapeutic Goods Administration)
lamivudine, Quantity: 300 mg; abacavir hydrochloride monohydrate, Quantity: 714.162 mg (Equivalent: abacavir, Qty 600 mg)
Lupin Australia Pty Limited
abacavir hydrochloride monohydrate,Lamivudine
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; ferric oxide; titanium dioxide; hypromellose; sunset yellow FCF; polysorbate 80; macrogol 400
Oral
30 tablets (HDPE bottle with PP child-resistant closure)
(S4) Prescription Only Medicine
ABACAVIR/LAMIVUDINE LUPIN is a combination of two nucleoside analogues (abacavir and lamivudine). ABACAVIR/LAMIVUDINE LUPIN is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age.
Visual Identification: Orange coloured, modified capsule shaped, biconvex, film-coated tablets debossed with 300 on one side and 600 on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2017-10-06